TY - JOUR
AU1 - Noguchi, Masakuni
AU2 - Koyasaki, Naohiro
AU3 - Ohta, Nagayoshi
AU4 - Kitagawa, Hirohisa
AU5 - Earashi, Mitsuharu
AU6 - Thomas, Michael
AU7 - Miyazaki, Itsuo
AU8 - Mizukami, Yuji
AB - Abstract • We evaluated the relationship among DNA ploidy, c-erb 8-2 oncoprotein expression, and clinicopathologic prognostic factors, especially axillary and internal mammary node metastases, and their value in estimating the prognosis in 128 patients with operable breast cancer. There were significant correlations between DNA ploidy and clinical stage, tumor size, or axillary or internal mammary lymph node metastases, and between c-erb B-2 expression and clinical stage or axillary lymph node metastases. In a univariate study, overall or disease-free survival was significantly correlated to clinical stage, tumor size, DNA ploidy, c-erb B-2 expression, and axillary and internal mammary node metastases. In a multivariate study, however, only axillary and internal mammary node metastases were recognized as independent factors on overall survival, whereas on disease-free survival, only axillary lymph node metastases were idenitifed as an independent indicator. Since the DNA ploidy status and c-erb B-2 expression were closely correlated with the axillary and/or internal mammary lymph node metastases, they did not appear as independent prognostic factors in this small series. (Arch Surg. 1993;128:242-246) References 1. Adair F, Berg J, Joubert L, Robbins GF. Long-term follow-up of breast cancer patients: the 30-year report . Cancer . 1974;33:1145-1150.Crossref 2. Consensus conference: adjuvant chemotherapy for breast cancer . JAMA . 1985;254:3461-3463.Crossref 3. McGuire WL, Dressier LG. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients . J Natl Cancer Inst . 1985;75:405-410. 4. Cornelisse CJ, van de Velde CJH, Casper RJC, Moolenaar AJ, Hermans J. DNA ploidy and survival in breast cancer patients . Cytometry . 1987;8: 225-234.Crossref 5. Kakkioniemi OP, Blanco G, Alavaikko M, et al. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: a proposed classification of DNA histograms in breast cancer . Cancer . 1988:62:2183-2190.Crossref 6. Slamon DJ, Clark GM, Wong SG, Levin WJ; Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplication of the HER-2/neu oncogene . Science . 1987;235:177-182.Crossref 7. Wright C, Angus B, Nicholson S, et al. Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer . Cancer Res . 1989;49: 2087-2090. 8. Berger MS, Locher GW, Saurer S, et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading . Cancer Res . 1988;48:1238-1243. 9. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer . Science . 1989;244: 707-712.Crossref 10. Morrow M, Foster RS. Staging of breast cancer . Arch Surg . 1981;116: 748-751.Crossref 11. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes . Ann Surg . 1985;202:702-707.Crossref 12. Schutte B, Reynders MMJ, Bosman FT, Blijham GH. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue . Cytometry . 1985;6:26-30.Crossref 13. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry . J Histochem Cytochem . 1983;31: 1333-1335.Crossref 14. Noguchi M, Ohta N, Koyasaki N, et al. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer . Cancer . 1991;68:1918-1925.Crossref 15. Gullick WJ, Berger MS, Bennett PLP, Rothbard JB, Waterfield MD. Expression of the c-erb B-2 protein in normal and transformed cells . Int J Cancer . 1987;40:246-254.Crossref 16. Japan Breast Cancer Society. General Rule for Clinical and Pathological Record of Breast Cancer . 9th ed. Tokyo, Japan: Kinbara Co; 1988. 17. World Health Organization. The World Health Organization histological typing of breast tumors—second edition . Am J Clin Pathol . 1982;78: 806-816. 18. Clark GM, Dressier LG, Owens MA, Pounds G, Oldaker T, McGuire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry . N Engl J Med . 1989:320;627-633. 19. Von Rosen A, Rutqvist LE, Carstensen J, Fallenius A, Skoog L, Auer G. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status and estrogen receptor content . Breast Cancer Res Treat . 1989;13:23-32.Crossref 20. Hedley DW, Rugg CA, Gelber RD. Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer . Cancer Res . 1987;47:4729-4735. 21. Uyterlinde AM, Schipper NW, Raak JPA. Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer . J Clin Pathol . 1987;40:1432-1436.Crossref 22. Moran RE, Black MM, Alpert L, Strauss MJ. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer . Cancer . 1984;54:1586-1590.Crossref 23. Beerman H, Kluin PM, Hermans J, van de Velde CJH, Cornelisse CJ. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients . Int J Cancer . 1990;45:34-39.Crossref 24. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL. HER-2/neu oncogene protein and prognosis in breast cancer . J Clin Oncol . 1989; 7:1120-1128. 25. Borg A, Tandon AK, Sigurdsson H, et al. HER-2/neu amplification predicts poor survival in node positive breast cancer . Cancer Res . 1990;50: 4332-4337. 26. Richner J, Gerber HA, Locher GW, et al. C-erbB-2 protein expression in node negative breast cancer . Ann Oncol . 1990;1:263-268. 27. Lewis WE. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients . Cancer . 1990;65:2315-2320.Crossref 28. Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, De-Cenzo J, Young D. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma? Cancer . 1990;65:1577-1582.Crossref 29. Nemoto T, Tominaga T, Chamberlain A, et al. Differences in breast cancer between Japan and the United States . J Natl Cancer Inst . 1977;58: 193-197. 30. Fisher B. The revolution in breast cancer surgery: science or anecdotalism? World J Surg . 1985;9:655-666.Crossref 31. Toikkanen S, Joensuu H, Klemi P. Nuclear DNA content as a prognostic factor in T1-2 and 0 breast cancer . Am J Clin Pathol . 1990; 93:471-479. 32. Winchester D, Dudarb J, August CZ, et al. The importance of DNA flow cytometry and node negative breast cancer . Arch Surg . 1990;125: 886-889.Crossref 33. Fischer B, Gunduz N, Constantino J, et al. DNA flow cytometric analysis of primary operable breast cancer: relation of ploidy and S-phase fraction outcome of patients in NSABP B-04 . Cancer . 1991;68: 1465-1475.Crossref 34. Lewis WE. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients . Cancer . 1990;65:2315-2320.Crossref
TI - Internal Mammary Nodal Status Is a More Reliable Prognostic Factor Than DNA Ploidy and c-erb B-2 Expression in Patients With Breast Cancer
JF - Archives of Surgery
DO - 10.1001/archsurg.1993.01420140119020
DA - 1993-02-01
UR - https://www.deepdyve.com/lp/american-medical-association/internal-mammary-nodal-status-is-a-more-reliable-prognostic-factor-Bkuqk5mbeo
SP - 242
EP - 246
VL - 128
IS - 2
DP - DeepDyve
ER -